Wegovy, Zepbound makers' stocks rally as a weight-loss-drug competitor drops out

That was music to the ears of investors in Novo Nordisk, which makes diabetes and obesity treatments Ozempic and Wegovy; and in Eli Lilly, which makes Mounjaro and Zepbound diabetes and obesity drugs.